Andreas H Marx

Summary

Affiliation: University Medical Center Hamburg-Eppendorf
Country: Germany

Publications

  1. doi request reprint Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis
    Andreas H Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Histopathology 57:418-26. 2010
  2. doi request reprint AMACR expression in colorectal cancer is associated with left-sided tumor localization
    Andreas Marx
    Institute for Pathology, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Virchows Arch 453:243-8. 2008
  3. doi request reprint Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease
    Andreas Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany
    Hum Pathol 40:166-73. 2009
  4. doi request reprint HER-2 amplification is highly homogenous in gastric cancer
    Andreas H Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Germany
    Hum Pathol 40:769-77. 2009
  5. doi request reprint Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers
    Andreas H Marx
    Institute for Pathology, Hubertus Wald Tumorzentrum University Cancer Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Hum Pathol 41:1577-85. 2010
  6. doi request reprint Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung
    Tobias J Grob
    Department of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Mod Pathol 25:1566-73. 2012
  7. pmc ALCAM (CD166) expression and serum levels in pancreatic cancer
    Michael Tachezy
    Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    PLoS ONE 7:e39018. 2012
  8. doi request reprint Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer
    Matthias Choschzick
    Institute of Pathology, University Medical Centre Hamburg Eppendorf, 20246 Hamburg, Germany
    Hum Pathol 41:358-65. 2010
  9. doi request reprint ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients
    Michael Tachezy
    Department of General, Visceral, and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Surg Res 170:226-32. 2011
  10. doi request reprint Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer
    Winfried H Alsdorf
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Exp Mol Pathol 94:155-9. 2013

Collaborators

Detail Information

Publications12

  1. doi request reprint Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis
    Andreas H Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Histopathology 57:418-26. 2010
    ..The aim of this study was performed to determine the potential impact of tumour heterogeneity on anti-EGFR therapy in Barrett's adenocarcinoma (BAC)...
  2. doi request reprint AMACR expression in colorectal cancer is associated with left-sided tumor localization
    Andreas Marx
    Institute for Pathology, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Virchows Arch 453:243-8. 2008
    ..We hypothesize that the association of AMACR expression with tumor localization may be related to differences in the metabolism/exposure to fatty acids occurring along the colon...
  3. doi request reprint Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease
    Andreas Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany
    Hum Pathol 40:166-73. 2009
    ..It is concluded that combined alpha-methylacyl coenzyme A racemase/p53 analysis may represent a helpful tool to confirm dysplasia in inflammatory bowel disease...
  4. doi request reprint HER-2 amplification is highly homogenous in gastric cancer
    Andreas H Marx
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Germany
    Hum Pathol 40:769-77. 2009
    ..The high level of HER-2 amplification in combination with the homogeneity of its expression in primary and metastatic tumors argues for a possible therapeutic utility of trastuzumab in HER-2-amplified gastric adenocarcinomas...
  5. doi request reprint Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers
    Andreas H Marx
    Institute for Pathology, Hubertus Wald Tumorzentrum University Cancer Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    Hum Pathol 41:1577-85. 2010
    ..Heterogeneity of amplification may limit the utility of anti- HER-2 therapy in some of these tumors and therefore, adequate clinical trials are needed to further evaluate this approach...
  6. doi request reprint Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung
    Tobias J Grob
    Department of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Mod Pathol 25:1566-73. 2012
    ..Heterogeneity of amplification may limit the utility of anti-HER2 therapy in some of these tumors. Further attempts to assess the utility of HER2-targeting therapy in homogeneously amplified lung cancers appear to be justified...
  7. pmc ALCAM (CD166) expression and serum levels in pancreatic cancer
    Michael Tachezy
    Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    PLoS ONE 7:e39018. 2012
    ....
  8. doi request reprint Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer
    Matthias Choschzick
    Institute of Pathology, University Medical Centre Hamburg Eppendorf, 20246 Hamburg, Germany
    Hum Pathol 41:358-65. 2010
    ..These data support the potential utility of newly developed small molecule cell division cycle 7 inhibitors as a therapeutic alternative in at least a subset of breast carcinomas...
  9. doi request reprint ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients
    Michael Tachezy
    Department of General, Visceral, and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Surg Res 170:226-32. 2011
    ..The aim of this study was to determine the expression of ALCAM in PNET to learn more about the prevalence and clinical significance of ALCAM expression in PNET...
  10. doi request reprint Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer
    Winfried H Alsdorf
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Exp Mol Pathol 94:155-9. 2013
    ..This suggests heterogeneity of the primary tumor in respect to its KRAS status. We therefore aimed to examine the frequency and the extent of such intratumoral heterogeneity...
  11. pmc Omental infarction in the postpartum period: a case report and a review of the literature
    Michael Tachezy
    Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Martinistrase 52, 20246 Hamburg
    J Med Case Reports 4:368. 2010
    ..Omental infarction is a rare and often misdiagnosed clinical event with unspecific symptoms. It affects predominantly young and middle aged women...
  12. ncbi request reprint Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus
    Uta Reichelt
    Department of Pathology, University Medical Center Hamburg Eppendorf, University of Hamburg, Hamburg, Germany
    Mod Pathol 20:120-9. 2007
    ..The strong concordance of the HER-2 status in primary and metastatic cancers argues for a possible response of metastases from patients with HER-2-positive primary tumors to Herceptin...